 SUNNYVALE, Calif., July 06, 2021 GLOBE NEWSWIRE -- Silk Road Medical, Inc. Nasdaq: SILK, a company focused on reducing the risk of stroke and its devastating impact, today announced that key data regarding standard risk patients undergoing treatment for atherosclerotic carotid disease, including patients undergoing carotid endarterectomy CEA and transcarotid artery revascularization TCAR, will be presented at the upcoming Society for Vascular Surgery 2021 Vascular Annual Meeting VAM, August 18 21 at the San Diego Convention Center in San Diego, California. 